1) Microvascular complications
微血管并发症
1.
Objective:To assess the prevalence of obesity,hypertension, diabetic microvascular complications and the risk factors associated with diabetic microvascular complications of T2DM patients from the diabetic complication assessment database of PLA 306 hospital from 1994.
目的研究1994年1月~2006年12月在解放军306医院参加糖尿病并发症筛查的2型糖尿病患者的肥胖症患病率、高血压患病率、糖尿病微血管并发症患病率及糖尿病微血管并发症的临床相关因素,并与同期全国的调查结果相比较,为糖尿病微血管并发症临床治疗与预防提供参考依据。
2) microvascular complication
微血管并发症
1.
Changes in plasma endothelin-1 and atrial natrinretic factor in microvascular complication of IDDM;
1型糖尿病微血管并发症血浆内皮素和心钠素的变化
2.
Objective To study the correlationship between blood fluctuation and microvascular complication in type 2 diabetes mellitus patients with glycosylated hemoglobin(HbA1c) levels <7%.
目的:探讨糖化血红蛋白(HbA1c)<7%的2型糖尿病(DM2)患者血糖波动与微血管并发症的关系。
4) Diabetic micro-angiopathy
糖尿病性微血管并发症
5) vascular complication
血管并发症
1.
Relationship between serum uric acid and insulin resistance and vascular complications of type 2 diabetes;
血尿酸与2型糖尿病胰岛素抵抗及血管并发症的关系
2.
Results: Serum TG,TC,LDL-C,ApoB level elevated in diabetic patients and high TG,TC,LDL-C,ApoB level may be an important risk factor for type 2 diabetic vascular complications.
结果:提示2型糖尿病患者血清血脂中TG、TC、LDL-C、ApoB水平升高是血管并发症的危险因素,而HDL-C、ApoA1(抗动脉粥样硬化的指标)则明显下降。
3.
Objective To explore the occurrence of vascular complications after applying BoomerangTM(vascular closure device) to block femoral artery.
目的探讨心脏介入治疗患者应用BoomerangTM血管封堵器封堵股动脉后血管并发症的发生情况。
6) vascular complications
血管并发症
1.
The relationship between excretion rate of urinary album and vascular complications of diabetes;
尿微量白蛋白排泄率与糖尿病血管并发症的关系
2.
Objective To investigate the change of plasma von Willebrand factor cleaving protease(vWF-cp) activity level in patients with type 2 diabetes mellitus(T2DM) and to study its clinical significance in diabetes mellitus vascular complications.
目的检测2型糖尿病患者血浆血管性血友病因子裂解酶(vWF-cp)活性,探讨其在糖尿病血管并发症中的意义。
3.
Methods A clinical analyses of 30 type 2 diabetic patients with vascular complications (group A) was conducted in comparison with type 2 diabetic patients without vascular complications (group B) and patients with impaired glucose tolerance (IGT, group C).
方法选择2型糖尿病合并肾病患者30例(A组),并与2型糖尿病无血管并发症者(B组)、糖耐量受损(IGT)者(C组)作比较;同时选择有2型糖尿病家族史健康人(D组)和无2型糖尿病家族史健康人(E组)各30例作为对照,分别检测UM、ET并进行统计分析。
补充资料:并发症
并发症
complication
又称“合并症”,指在一种疾病的发展过程中引起的另一种疾病或症状,常把后者称为前者的并发症。早期而积极的治疗可以减少并发症的发生。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条